Hims & Hers Reports Strong Q1 and Growth Targets for 2030 – More Partnerships Expected After Novo Nordisk
Reading Time: 3 minutes
Hims & Hers can more than double revenue and increase the number of subscribers by 38% to 2.4 million. 1.4 million subscribers already use personalized offers. Deepening personalization, enhancing subscription experiences, and new specialty areas and partnerships as important strategic goals. By 2030, revenue is expected to reach at least $6.5 billion and adjusted EBITDA to increase to $1.3 billion. The Wegovy partnership with Novo Nordisk is a milestone. The transition of semaglutide users to alternative weight therapies will temporarily...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
